Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

A prospective comparative study between prewarming and cowarming to prevent intraoperative hypothermia.

Shenoy L, Krishna HM, Kalyan N, Prasad KH.

J Anaesthesiol Clin Pharmacol. 2019 Apr-Jun;35(2):231-235. doi: 10.4103/joacp.JOACP_353_17.

2.

Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.

Clarke DK, Nasar F, Chong S, Johnson JE, Coleman JW, Lee M, Witko SE, Kotash CS, Abdullah R, Megati S, Luckay A, Nowak B, Lackner A, Price RE, Little P, Kalyan N, Randolf V, Javadian A, Zamb TJ, Parks CL, Egan MA, Eldridge J, Hendry M, Udem SA.

J Virol. 2014 Jun;88(12):6690-701. doi: 10.1128/JVI.03441-13. Epub 2014 Apr 2.

3.

A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.

Donald RG, Flint M, Kalyan N, Johnson E, Witko SE, Kotash C, Zhao P, Megati S, Yurgelonis I, Lee PK, Matsuka YV, Severina E, Deatly A, Sidhu M, Jansen KU, Minton NP, Anderson AS.

Microbiology. 2013 Jul;159(Pt 7):1254-66. doi: 10.1099/mic.0.066712-0. Epub 2013 Apr 29.

4.

Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.

Johnson JE, McNeil LK, Megati S, Witko SE, Roopchand VS, Obregon JH, Illenberger DM, Kotash CS, Nowak RM, Braunstein E, Yurgelonis I, Jansen KU, Kalyan NK, Sidhu MK.

Immunol Lett. 2013 Feb;150(1-2):134-44. doi: 10.1016/j.imlet.2012.12.005. Epub 2012 Dec 20.

PMID:
23261719
5.

Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression.

Witko SE, Johnson JE, Kalyan NK, Felber BK, Pavlakis GN, Sidhu MK, Hendry RM, Udem SA, Parks CL.

J Virol Methods. 2010 Mar;164(1-2):43-50. doi: 10.1016/j.jviromet.2009.11.023. Epub 2009 Nov 24.

6.

In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Johnson JE, Coleman JW, Kalyan NK, Calderon P, Wright KJ, Obregon J, Ogin-Wilson E, Natuk RJ, Clarke DK, Udem SA, Cooper D, Hendry RM.

Vaccine. 2009 May 14;27(22):2930-9. doi: 10.1016/j.vaccine.2009.03.006. Epub 2009 Mar 13.

7.

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

Natuk RJ, Cooper D, Guo M, Calderon P, Wright KJ, Nasar F, Witko S, Pawlyk D, Lee M, DeStefano J, Tummolo D, Abramovitz AS, Gangolli S, Kalyan N, Clarke DK, Hendry RM, Eldridge JH, Udem SA, Kowalski J.

J Virol. 2006 May;80(9):4447-57.

8.

Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay.

Kumar M, Khan IA, Verma V, Kalyan N, Qazi GN.

Diagn Microbiol Infect Dis. 2005 Oct;53(2):121-4. Epub 2005 Sep 15.

PMID:
16168616
9.

Insertion of HIV-1 genes into Ad4DeltaE3 vector abrogates increased pathogenesis in cotton rats due to E3 deletion.

Patterson LJ, Prince GA, Richardson E, Alvord WG, Kalyan N, Robert-Guroff M.

Virology. 2002 Jan 5;292(1):107-13.

10.

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.

Buge SL, Richardson E, Alipanah S, Markham P, Cheng S, Kalyan N, Miller CJ, Lubeck M, Udem S, Eldridge J, Robert-Guroff M.

J Virol. 1997 Nov;71(11):8531-41.

11.

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization.

Lubeck MD, Natuk R, Myagkikh M, Kalyan N, Aldrich K, Sinangil F, Alipanah S, Murthy SC, Chanda PK, Nigida SM Jr, Markham PD, Zolla-Pazner S, Steimer K, Wade M, Reitz MS Jr, Arthur LO, Mizutani S, Davis A, Hung PP, Gallo RC, Eichberg J, Robert-Guroff M.

Nat Med. 1997 Jun;3(6):651-8.

PMID:
9176492
12.

Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1.

Kalyan NK, Lee SG, Wilhelm J, Pisano MR, Hum WT, Hsiao CL, Davis AR, Eichberg JW, Robert-Guroff M, Hung PP.

Vaccine. 1994 Jun;12(8):753-60.

PMID:
7522383
13.

Ultrastructural characterization of human immunodeficiency virus type 1 Gag-containing particles assembled in a recombinant adenovirus vector system.

Vernon SK, Murthy S, Wilhelm J, Chanda PK, Kalyan N, Lee SG, Hung PP.

J Gen Virol. 1991 Jun;72 ( Pt 6):1243-51.

PMID:
2045790
14.

Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life.

Weinheimer CJ, James HL, Kalyan NK, Wilhelm J, Lee SG, Hung PP, Sobel BE, Bergmann SR.

Circulation. 1991 Apr;83(4):1429-36.

PMID:
1901531
15.

Deglycosylation increases the fibrinolytic activity of a deletion mutant of tissue-type plasminogen activator.

Wilhelm J, Kalyan NK, Lee SG, Hum WT, Rappaport R, Hung PP.

Thromb Haemost. 1990 Jun 28;63(3):464-71.

PMID:
2119528
16.

Alterations in the domain structure of tissue-type plasminogen activator change the nature of asparagine glycosylation.

Wilhelm J, Lee SG, Kalyan NK, Cheng SM, Wiener F, Pierzchala W, Hung PP.

Biotechnology (N Y). 1990 Apr;8(4):321-5.

PMID:
1367433
17.

Biological properties of hybrid plasminogen activators.

Hung PP, Wilhelm J, Kalyan NK, Cheng SM, James HL, Nachowiak D, Weinheimer CJ, Sobel BE, Bergmann SR, Lee SG.

Adv Exp Med Biol. 1990;281:201-8.

PMID:
2129369
18.

Synthesis and refolding of human tissue-type plasminogen activator in Bacillus subtilis.

Wang LF, Hum WT, Kalyan NK, Lee SG, Hung PP, Doi RH.

Gene. 1989 Dec 7;84(1):127-33.

PMID:
2514121
19.

Isolation of a human cDNA of urokinase and its expression in COS-1 cells.

Cheng SM, Lee SG, Kalyan NK, Hum WT, Blume M, Vogel R, Hung PP.

Gene. 1988 Sep 30;69(2):357-63.

PMID:
3234771
20.

Expression and secretion of human atrial natriuretic alpha-factor in Bacillus subtilis using the subtilisin signal peptide.

Wang LF, Wong SL, Lee SG, Kalyan NK, Hung PP, Hilliker S, Doi RH.

Gene. 1988 Sep 15;69(1):39-47.

PMID:
2976012
22.

Clearance of a novel recombinant tissue plasminogen activator in rabbits.

Fu KP, Lee S, Hetzel N, Fenichel R, Hum HW, Speth J, Kalyan N, Hung PP.

Thromb Res. 1988 Jun 1;50(5):679-85.

PMID:
3137685
23.

Disposition of a novel recombinant tissue plasminogen activator, delta 2-89 TPA, in mice.

Fu KP, Lee S, Hum WT, Kalyan N, Rappaport R, Hetzel N, Hung PP.

Thromb Res. 1988 Apr 1;50(1):33-41.

PMID:
3135637
24.

Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.

Kalyan NK, Lee SG, Wilhelm J, Fu KP, Hum WT, Rappaport R, Hartzell RW, Urbano C, Hung PP.

J Biol Chem. 1988 Mar 15;263(8):3971-8.

25.

Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.

Lee SG, Kalyan N, Wilhelm J, Hum WT, Rappaport R, Cheng SM, Dheer S, Urbano C, Hartzell RW, Ronchetti-Blume M, et al.

J Biol Chem. 1988 Feb 25;263(6):2917-24.

26.

Tissue plasminogen activator (tPA) as a reporter gene in transient gene expression.

Cheng SM, Lee SG, Kalyan NK, McCloud S, Levner M, Hung PP.

Gene. 1987;58(2-3):299-303.

PMID:
2828192
27.
29.
30.

Effect of modification of galactose residues on the biological properties of asialo human choriogonadotropin.

Madnick HM, Kalyan NK, Segal HL, Bahl OP.

Arch Biochem Biophys. 1981 Dec;212(2):432-42. No abstract available.

PMID:
7325669
31.

Effect of deglycosylation on the subunit interactions and receptor binding activity of human chorionic gonadotropin.

Kalyan NK, Bahl OP.

Biochem Biophys Res Commun. 1981 Oct 30;102(4):1246-53. No abstract available.

PMID:
6172122
32.

Biochemical changes in the cervical mucus of buffalo after induction of oestrus with prostaglandin F-2 alpha and cloprostenol.

Prasad A, Kalyan NK, Bachlaus NK, Arora RC, Pandey RS.

J Reprod Fertil. 1981 Jul;62(2):583-7.

PMID:
7195941
33.

Isolation and purification of erythrocyte catalase of buffalo (Bubalus bubalis).

Sharma MK, Bachlaus NK, Kalyan NK, Batra SK, Pandey RS.

Zentralbl Veterinarmed A. 1980 Jul;27(5):414-20. No abstract available.

PMID:
6776717
34.

Studies on the comparative characteristics of erythrocyte catalase in cattle, buffalo & goat.

Sharma MK, Bachlaus NK, Kalyan NK, Pandey RS.

Indian J Biochem Biophys. 1977 Dec;14(4):330-3. No abstract available.

PMID:
615101

Supplemental Content

Loading ...
Support Center